Starbucks (SBUX) at 55x Earnings: Is the Recovery Priced In?
Starbucks reported global comparable sales up 7.9% in its fiscal third quarter, and the stock still sits around $95.83 as I write this, about 12.8% below its 52-week high of $110. That gap is the whole puzzle. A business that just posted its best comp number in years, and raised its earnings guidance on top of it, is priced at 55.4 times trailing earnings, against a five-year average near 36.5. Either the market already paid for the recovery, or trailing earnings are still so depressed that the multiple is misleading. I think it is mostly the second, with an important catch.
Here is my position on it. The comp-sales turnaround at Starbucks is real, it is broad enough to trust, and the forward multiple of about 33.1 makes the stock fair rather than cheap. I would call it a business worth owning on a pullback and not one worth chasing at the highs, and the rest of this piece is the evidence for that.
Two years of negative comps, then this
Some context helps here. For roughly two years the Starbucks story was traffic decline. Stores that were built as a place to sit had become a pickup counter for mobile orders, wait times stretched, and each new plan for fixing it sounded like the previous one. I have been skeptical of turnaround stories for a long time, and my rule for this one was simple: I wanted the fix to show up in the comparable-sales line, not in a slide deck.
It has now shown up. According to the company’s fiscal third quarter release, global comparable sales rose 7.9%, with North America up about 8.1% and the gain led by transactions, meaning more customers and not just higher prices. That distinction matters. A comp driven by price increases can be repeated only until customers push back. A comp driven by traffic says the stores are working again.
Adjusted earnings per share came in at $0.85 for the quarter, against $0.50 in the same quarter a year earlier. That is a 70% jump in twelve months. Management then raised full-year adjusted EPS guidance to a range of $2.55 to $2.65, up from $2.25 to $2.45, and lifted its comp outlook to nearly 6% globally and slightly above 6% in the U.S., from at least 5% for both.
One good quarter after a bad stretch is noise. This is the run of results after that, and the guidance raises are what make it more credible, because a company that expects to disappoint does not usually lift its own bar.
What the margin line is telling me
Revenue for fiscal 2025 was $37.2 billion, up 3% from $36.2 billion a year earlier. Growth of that size hides the real damage, which happened lower on the income statement. Net income fell from $3.8 billion to $1.9 billion, and gross margin slid from 26.8% to 22.8%. Starbucks was selling about the same amount of coffee and keeping far less of it.
So the margin recovery is what should be watched. In the third quarter the company reported an operating margin of 14.4%, up 430 basis points, and credited sales strength, cost savings, lower inflation and tariff refunds. I read the first two as durable and the last two as things that can reverse. Coffee prices and tariff policy are not in Starbucks’ control, and refunds in particular are not something to capitalize at a full multiple.
Full-year operating margin guidance above 11% is a more useful anchor than the single quarter. Fiscal 2025 operating margin was about 10% on a reported basis, so 11% is an improvement, but it is nowhere near the margins the company earned before 2024. If a holder wants to know how much recovery is left, the gap between 11% and that older level is the answer, and it is the reason the forward earnings estimate of $2.90 per share in my data looks reachable and not conservative.
Why the trailing P/E misleads
A price-to-earnings ratio of 55.4 looks absurd for a company that sells coffee. The reason is the denominator: trailing earnings of $1.73 per share include the worst stretch of the cycle. Swap in the $2.90 forward estimate and the multiple drops to roughly 33.1. That is still above the five-year average of 36.5, which tells me the market is paying for a margin recovery that has only partly arrived.
I like to run a simple hypothetical here. Suppose a holder buys around today’s price and the company earns the top of its current guidance range, $2.65, this fiscal year. The stock would then trade near 36 times that figure. If the market keeps giving the stock its historical multiple, the return comes only from earnings growth from there, and it depends on the recovery continuing into next year. That is a fair setup and not a bargain one. A pullback would change it, and the 52-week low of $76 would put the forward multiple in the mid-20s on the same estimates.
Starbucks also pays a dividend of $2.47 per share, a yield of 2.58%. Modest, but it means a patient holder is paid something while waiting for the multiple to settle.
| Metric | Value | Context |
|---|---|---|
| Share price | $95.83 | 52-week range $76 to $110 |
| P/E (trailing) | 55.4 | five-year average 36.5 |
| P/E (forward) | 33.1 | on $2.90 estimated EPS |
| Fiscal 2025 revenue | $37.2 billion | up 3% from $36.2 billion |
| Gross margin | 22.8% | down from 26.8% a year earlier |
| Analyst target (average) | $119 | range $110 to $143, 19 analysts |
What the analyst targets do and do not say
The 19 analysts in my data put the average price target at $119, about 24% above the current price, with a low of $110 and a high of $143. Even the lowest target sits above today’s price. About 63% of them rate the stock a buy.
I do not put much weight on that. Targets follow prices; they get raised after a good quarter and cut after a bad one. What I take from the range is narrower. Nobody covering the stock thinks the recovery has failed, and the debate has moved from whether the turnaround works to how much of it is already in the price. That is a healthier debate than the one two years ago, and it is also a crowded one.
The cost of a full recovery
Nike is the closest comparison I have written about. In my Nike piece the argument was about a scoreboard: a turnaround only counts once a specific number moves. The Starbucks scoreboard is comp sales and operating margin, and it is moving. The difference is that Nike is still waiting for its numbers, while Starbucks has delivered a quarter and now has to repeat it. Intel is at the other extreme, and that piece is about a turnaround with a deadline and no proof yet.
A turnaround that has already produced numbers sits in an awkward spot for a buyer. The easy money, from a depressed price and low expectations, went to people who bought when the comps were negative. Anyone buying now is paying for the next four quarters to be as good as the last one. That can happen. It just leaves less room for a stumble, and Starbucks stumbles have historically been sharp.
How I could be wrong
The strongest counter-case is that the third quarter was as good as it gets. Tariff refunds and lower inflation flattered the margin, the comparison base from a year earlier was easy, and the guidance for the rest of the year already assumes comps stay near 6%. If the next two quarters print comps at 3% to 4%, the stock does not need a bad quarter to fall, because a forward multiple in the low 30s leaves no cushion for deceleration.
There is a second risk that is easy to overlook. Traffic-driven comps at a chain that priced up heavily can reverse if the consumer weakens, and coffee is a discretionary purchase at these price points. I cannot tell from the filings how much of the transaction gain comes from promotions. The latest 10-Q on SEC EDGAR is where I would look for how the company describes traffic, ticket and mix, and I would read that language before trusting any single headline number.
I should also be honest about what I do not know. My data shows the last quarter’s revenue growth as roughly flat to slightly negative on a sequential and year-over-year basis, which does not obviously fit a 7.9% comp. I suspect that is a timing issue between the latest data pull and the most recent report, and I did not reconcile it to the filing, so treat the quarterly revenue trend as something to verify before acting on it.
The comp number I would watch
For the next print, my threshold is a global comparable-sales figure of 5% or better. That is the level the company itself set as its floor before this raise, and a result below it would tell me the quarter was the peak. If comps hold above 6% and operating margin stays above 11% on a full-year basis, the forward multiple starts to look earned, and I would be comfortable holding through volatility. If comps drop below 4%, I would expect the price to move toward the low end of the analyst range, and the low end of the trading range after that.
On the stock itself, the price near $95.83 is defensible and not compelling. I would rather see a pullback toward the low $80s, where the forward multiple would fall to around 28 times, before calling it an opportunity. Until then, this is a recovery I believe in at a price I do not love.
Analysis and opinion only, not investment advice. Figures come from Starbucks’ filings on SEC EDGAR and its investor site; valuation multiples are approximate and were checked on September 22, 2026.